Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
15 February 2024 - 8:20AM
Edgar (US Regulatory)
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
|
|
| |
| SCHEDULE 13G/A |
| |
| Under the Securities Exchange Act of 1934 |
| (Amendment No. 2)* |
| |
|
Abeona Therapeutics
Inc. |
| (Name of Issuer) |
| |
|
Common Stock, par
value $0.01 per share |
| (Title of Class of Securities) |
| |
|
00289Y206 |
| (CUSIP Number) |
| |
|
December 31, 2023 |
| (Date of Event Which Requires Filing of this Statement) |
| |
| |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
| |
| ¨ |
Rule 13d-1(b) |
| ý |
Rule 13d-1(c) |
| ¨ |
Rule 13d-1(d) |
| |
| (Page 1 of 7 Pages) |
______________________________
*The remainder of this
cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required
in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
| CUSIP No. 00289Y206 | 13G/A | Page 2 of 7 Pages |
| 1 |
NAME OF REPORTING PERSON
Point72 Asset Management, L.P. |
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) x |
| 3 |
SEC USE ONLY |
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
0 |
| 6 |
SHARED VOTING POWER
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 7 |
SOLE DISPOSITIVE POWER
0 |
| 8 |
SHARED DISPOSITIVE POWER
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.4% |
| 12 |
TYPE OF REPORTING PERSON
PN |
| |
|
|
|
|
| CUSIP No. 00289Y206 | 13G/A | Page 3 of 7 Pages |
| 1 |
NAME OF REPORTING PERSON
Point72 Capital Advisors, Inc. |
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) x |
| 3 |
SEC USE ONLY |
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
0 |
| 6 |
SHARED VOTING POWER
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 7 |
SOLE DISPOSITIVE POWER
0 |
| 8 |
SHARED DISPOSITIVE POWER
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.4% |
| 12 |
TYPE OF REPORTING PERSON
CO |
| |
|
|
|
|
| CUSIP No. 00289Y206 | 13G/A | Page 4 of 7 Pages |
| 1 |
NAME OF REPORTING PERSON
Steven A. Cohen |
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) x |
| 3 |
SEC USE ONLY |
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
0 |
| 6 |
SHARED VOTING POWER
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 7 |
SOLE DISPOSITIVE POWER
0 |
| 8 |
SHARED DISPOSITIVE POWER
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,649,740 (including 888,870 shares of Common Stock issuable
upon exercise of warrants) |
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.4% |
| 12 |
TYPE OF REPORTING PERSON
IN |
| |
|
|
|
|
| CUSIP No. 00289Y206 | 13G/A | Page 5 of 7 Pages |
| Item 1(a). |
Name of Issuer. |
| |
Abeona Therapeutics Inc. (the “Issuer”). |
| Item 1(b). |
Address of Issuer's Principal Executive Offices. |
| |
6555 Carnegie Avenue, 4th Floor, Cleveland, OH 44103. |
| Item 2(a). |
Name of Person Filing. |
| |
This statement is filed by:
(i) Point72 Asset Management, L.P. (“Point72 Asset Management”) with respect to shares of common stock, par value $0.01
per share (“Common Stock”), of the Issuer held by Point72 Associates, LLC, an investment fund it manages (“Point72
Associates”); (ii) Point72 Capital Advisors, Inc. (“Point72 Capital Advisors Inc.”) with respect to Common
Stock held by Point72 Associates; and (iii) Steven A. Cohen (“Mr. Cohen”) with respect to Common Stock beneficially
owned by Point72 Asset Management and Point72 Capital Advisors Inc.
|
| Item 2(b). |
Address of Principal Business Office. |
| |
The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902. |
| Item 2(c). |
Place of Organization. |
| |
Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen. |
| Item 2(d). |
Title of Class of Securities. |
| |
Common Stock, par value $0.01 per share. |
| Item 2(e). |
CUSIP Number. |
| |
00289Y206 |
| Item 3. |
If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a: |
| |
Not applicable. |
| Item 4. |
Ownership. |
| |
The information required by Items 4(a) – (c)
is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each
Reporting Person. Such information is as of the close of business on December 31, 2023.
Point72 Asset Management, Point72 Capital Advisors
Inc., and Mr. Cohen own directly no Common Stock. Pursuant to an investment management agreement, Point72 Asset Management maintains investment
and voting power with respect to the securities held by Point72 Associates. Point72 Capital Advisors Inc. is the general partner of Point72
Asset Management. Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc. The filing of this statement should
not be construed as an admission that any of the foregoing persons or any reporting person is, for the purposes of Section 13 of the Act,
the beneficial owner of the Common Stock reported herein.
The aggregate percentage of the Common Stock reported
to be beneficially owned by each Reporting Person is based on 25,662,187 shares of Common Stock outstanding which is the sum of: (i) 24,773,317
shares of Common Stock outstanding as of November 1, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with
the Securities and Exchange Commission on November 13, 2023; and (ii) 888,870 warrant shares exercised as reported herein. |
| CUSIP No. 00289Y206 | 13G/A | Page 6 of 7 Pages |
| Item 5. |
Ownership of Five Percent or Less of a Class. |
| |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. |
| |
|
| Item 6. |
Ownership of More Than Five Percent on Behalf of Another Person. |
| |
Point72 Associates has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the outstanding shares of Common Stock. |
| |
|
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not applicable. |
| |
|
| Item 8. |
Identification and Classification of Members of the Group. |
| |
Not applicable. |
| |
|
| Item 9. |
Notice of Dissolution of Group. |
| |
Not applicable.
|
| Item 10. |
Certification. |
| |
By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
| |
|
| CUSIP No. 00289Y206 | 13G/A | Page 7 of 7 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge
and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
| Date: February 14, 2024 |
|
| |
POINT72 ASSET MANAGEMENT, L.P. |
| |
|
| |
By: /s/ Jason M. Colombo |
| |
Name: Jason M. Colombo |
| |
Title: Authorized Person
|
| |
POINT72 CAPITAL ADVISORS, INC. |
| |
|
| |
By: /s/ Jason M. Colombo |
| |
Name: Jason M. Colombo |
| |
Title: Authorized Person |
| |
| STEVEN A. COHEN |
| |
| By: /s/ Jason M. Colombo |
| Name: Jason M. Colombo |
| Title: Authorized Person |
| |
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Apr 2023 to Apr 2024
